Retraction: ‘HOXD-AS1 confers cisplatin resistance in gastric cancer through epigenetically silencing PDCD4 via recruiting EZH2’ (2019), by Ye et al.

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society 2023
Materias:
Retractions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10485898/
https://www.ncbi.nlm.nih.gov/pubmed/37681498
http://dx.doi.org/10.1098/rsob.230322

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10485898/
https://www.ncbi.nlm.nih.gov/pubmed/37681498
http://dx.doi.org/10.1098/rsob.230322

Ejemplares similares